Mednow Inc. Logo

Mednow Inc.

MNOW.V

(1.2)
Stock Price

0,02 CAD

-117.38% ROA

672.77% ROE

-0.03x PER

Market Cap.

517.288,00 CAD

-151.31% DER

0% Yield

-37.61% NPM

Mednow Inc. Stock Analysis

Mednow Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Mednow Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-0.08x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (-151%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

4 ROE

The stock's ROE indicates a negative return (-25821.55%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-240.2%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Mednow Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Mednow Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Mednow Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Mednow Inc. Revenue
Year Revenue Growth
2020 0
2021 414.000 100%
2022 16.638.670 97.51%
2023 51.143.652 67.47%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Mednow Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Mednow Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2020 385.940
2021 8.314.729 95.36%
2022 19.840.321 58.09%
2023 18.388.120 -7.9%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Mednow Inc. EBITDA
Year EBITDA Growth
2020 -469.502
2021 -8.751.670 94.64%
2022 -19.846.354 55.9%
2023 -12.324.596 -61.03%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Mednow Inc. Gross Profit
Year Gross Profit Growth
2020 0
2021 414.000 100%
2022 2.783.384 85.13%
2023 5.939.436 53.14%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Mednow Inc. Net Profit
Year Net Profit Growth
2020 -469.502
2021 -8.953.835 94.76%
2022 -29.482.917 69.63%
2023 -16.046.144 -83.74%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Mednow Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2020 0
2021 0 0%
2022 -1 100%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Mednow Inc. Free Cashflow
Year Free Cashflow Growth
2020 -532.015
2021 -6.603.088 91.94%
2022 -19.143.232 65.51%
2023 -376.497 -4984.56%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Mednow Inc. Operating Cashflow
Year Operating Cashflow Growth
2020 -433.093
2021 -5.588.326 92.25%
2022 -16.086.503 65.26%
2023 -376.497 -4172.68%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Mednow Inc. Capital Expenditure
Year Capital Expenditure Growth
2020 98.922
2021 1.014.762 90.25%
2022 3.056.729 66.8%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Mednow Inc. Equity
Year Equity Growth
2020 5.386.104
2021 32.486.740 83.42%
2022 6.009.480 -440.59%
2023 -5.827.158 203.13%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Mednow Inc. Assets
Year Assets Growth
2020 5.540.787
2021 34.171.322 83.79%
2022 18.131.993 -88.46%
2023 13.277.257 -36.56%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Mednow Inc. Liabilities
Year Liabilities Growth
2020 154.683
2021 1.684.582 90.82%
2022 12.122.513 86.1%
2023 19.104.415 36.55%

Mednow Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.57
Net Income per Share
-0.59
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0.02x
POCF Ratio
-0.08
PFCF Ratio
-0.09
Price to Book Ratio
-0.08
EV to Sales
0.24
EV Over EBITDA
-0.82
EV to Operating CashFlow
-1.48
EV to FreeCashFlow
-1.43
Earnings Yield
-29.52
FreeCashFlow Yield
-11.05
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
1.86
Graham NetNet
-0.72

Income Statement Metrics

Net Income per Share
-0.59
Income Quality
0.43
ROE
6.73
Return On Assets
-0.96
Return On Capital Employed
5.35
Net Income per EBT
1
EBT Per Ebit
1.06
Ebit per Revenue
-0.36
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0.4
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.12
Operating Profit Margin
-0.36
Pretax Profit Margin
-0.38
Net Profit Margin
-0.38

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.26
Free CashFlow per Share
-0.27
Capex to Operating CashFlow
0.03
Capex to Revenue
-0.01
Capex to Depreciation
-0.09
Return on Invested Capital
-1.98
Return on Tangible Assets
-1.17
Days Sales Outstanding
30.89
Days Payables Outstanding
88.86
Days of Inventory on Hand
12.96
Receivables Turnover
11.82
Payables Turnover
4.11
Inventory Turnover
28.17
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,04
Book Value per Share
-0,26
Tangible Book Value per Share
-0.38
Shareholders Equity per Share
-0.26
Interest Debt per Share
0.41
Debt to Equity
-1.51
Debt to Assets
0.64
Net Debt to EBITDA
-0.77
Current Ratio
0.34
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-1.51
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0.18
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
1172596
Debt to Market Cap
16.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Mednow Inc. Dividends
Year Dividends Growth

Mednow Inc. Profile

About Mednow Inc.

Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies located in British Columbia, Manitoba, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

CEO
Simranveer Grewal
Employee
7
Address
595 Howe St.
Vancouver, V6C 2T5

Mednow Inc. Executives & BODs

Mednow Inc. Executives & BODs
# Name Age
1 Simranveer Grewal
Vice President of Technology
70
2 Ms. Lindsay Nahmiache
Member of Advisory Board - Marketing Advisor
70
3 Mr. Dave Marantz
Chief Revenue Officer
70

Mednow Inc. Competitors